Five‐Year Outcomes and Clinicopathological Correlations of Kidney Transplants From Deceased Donors With Diabetes

ABSTRACT Background Kidneys from deceased donors with diabetes mellitus are refused because diabetes is considered a marker of lower organ quality. We evaluated 5‐year outcomes according to donor‐recipient diabetes status and, secondarily, the prognostic value of pre‐implantation histopathological findings among accepted diabetic donor kidneys. Methods This retrospective single‐center cohort study included adult recipients of deceased‐donor kidney transplants performed between 2013 and 2017. Five‐year kidney function and death‐censored graft survival were compared according to donor diabetes status before and after 1:2 propensity score matching. A secondary exploratory analysis evaluated Banff chronicity parameters in pre‐implantation pathology reports. Results Among 3058 recipients, 244 received kidneys from diabetic donors. These donors were older, more frequently hypertensive, and had higher KDPI than non‐diabetic donors. In unadjusted analyses, recipients of diabetic donor kidneys had lower eGFR and death‐censored graft survival. After matching, eGFR from years 1 to 5, eGFR slope, and death‐censored graft survival no longer differed between groups. Recipient diabetes did not significantly modify the association of donor diabetes with graft survival or longitudinal eGFR, although the D+/R+ subgroup was small ( n = 39). Among 164 available pre‐implantation biopsy reports, diabetes‐related glomerular lesions were uncommon, chronic lesions were predominantly vascular and mild to moderate, and no Banff histological parameter independently predicted eGFR <30 mL/min/1.73 m 2 or death‐censored graft loss at 5 years. Conclusions After balancing baseline donor and recipient characteristics, donor diabetes was not associated with significantly lower 5‐year kidney function or death‐censored graft survival. In the secondary clinicopathological analysis, no individual Banff chronicity parameter independently predicted 5‐year outcomes.

Authors

Institutions

Publication Details

Journal
Clinical Transplantation
Published
2026-09-28
DOI
https://doi.org/10.1111/ctr.70698
Primary Topic
Renal Transplantation Outcomes and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

Five‐Year Outcomes and Clinicopathological Correlations of Kidney Transplants From Deceased Donors With Diabetes

Renato Demarchi Foresto, Henrique Proença, Pedro Henrique Moretti Pepato, Lúcio Requião-Moura et al.
Clinical Transplantation
Renal Transplantation Outcomes and Treatments
article

Five‐Year Outcomes and Clinicopathological Correlations of Kidney Transplants From Deceased Donors With Diabetes

Renato Demarchi Foresto, Henrique Proença, Pedro Henrique Moretti Pepato, Lúcio Requião-Moura, Jose Medina-Pestana¹, Marina Colella‐Santos, Luiz Antonio Ribeiro de Moura
article en

Abstract

ABSTRACT Background Kidneys from deceased donors with diabetes mellitus are refused because diabetes is considered a marker of lower organ quality. We evaluated 5‐year outcomes according to donor‐recipient diabetes status and, secondarily, the prognostic value of pre‐implantation histopathological findings among accepted diabetic donor kidneys. Methods This retrospective single‐center cohort study included adult recipients of deceased‐donor kidney transplants performed between 2013 and 2017. Five‐year kidney function and death‐censored graft survival were compared according to donor diabetes status before and after 1:2 propensity score matching. A secondary exploratory analysis evaluated Banff chronicity parameters in pre‐implantation pathology reports. Results Among 3058 recipients, 244 received kidneys from diabetic donors. These donors were older, more frequently hypertensive, and had higher KDPI than non‐diabetic donors. In unadjusted analyses, recipients of diabetic donor kidneys had lower eGFR and death‐censored graft survival. After matching, eGFR from years 1 to 5, eGFR slope, and death‐censored graft survival no longer differed between groups. Recipient diabetes did not significantly modify the association of donor diabetes with graft survival or longitudinal eGFR, although the D+/R+ subgroup was small ( n = 39). Among 164 available pre‐implantation biopsy reports, diabetes‐related glomerular lesions were uncommon, chronic lesions were predominantly vascular and mild to moderate, and no Banff histological parameter independently predicted eGFR <30 mL/min/1.73 m 2 or death‐censored graft loss at 5 years. Conclusions After balancing baseline donor and recipient characteristics, donor diabetes was not associated with significantly lower 5‐year kidney function or death‐censored graft survival. In the secondary clinicopathological analysis, no individual Banff chronicity parameter independently predicted 5‐year outcomes.

Clinical TransplantationVol. 40(10)
Hospital do Rim e Hipertensão (BR), Universidade Federal de São Paulo (BR)
Openalex Percentile: Top 9%
Renal Transplantation Outcomes and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.